NewslettersHematopoiesis NewsLow-Dose Fluconazole as a Useful and Safe Prophylactic Option in Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationBy lbeveridge - January 14, 20240101This retrospective study aimed to identify the group of patients who safely undergo allogeneic hematopoietic stem cell transplantation with low-dose fluconazoleprophylaxis[Cancer Medicine]Full Article